User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial

Primary tabs

download
  • Open access
  • PDF
  • 642.52 K
Van Keer, Jan Derthoo, David Van Caenegem, Olivier [UCL] De Pauw, Michel Nellessen, Eric Vanhaecke, Johan
Document type Article de périodique (Journal article) – Essai clinique
Access type Accès libre
Publication date 2017
Language Anglais
Journal information "Journal of Transplantation" - Vol. 2017, no.2017, p. 1-8 (2017)
Peer reviewed yes
Publisher Hindawi Publishing Corporation (New York)
issn 2090-0007
e-issn 2090-0015
Publication status Publié
Affiliations UCL - (MGD) Service de chirurgie cardio-vasculaire et thoracique
UCL - (MGD) Service de cardiologie
UCL - SSS/IREC - Institut de recherche expérimentale et clinique
Keywords heart transplantation ; everolimus ; renal failure
Links
  1. Flechner Stuart M, Kobashigawa Jon, Klintmalm Goran, Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity, 10.1111/j.1399-0012.2007.00739.x
  2. Ojo Akinlolu O., Held Philip J., Port Friedrich K., Wolfe Robert A., Leichtman Alan B., Young Eric W., Arndorfer Julie, Christensen Laura, Merion Robert M., Chronic Renal Failure after Transplantation of a Nonrenal Organ, 10.1056/nejmoa021744
  3. Yusen Roger D., Edwards Leah B., Kucheryavaya Anna Y., Benden Christian, Dipchand Anne I., Goldfarb Samuel B., Levvey Bronwyn J., Lund Lars H., Meiser Bruno, Rossano Joseph W., Stehlik Josef, The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report—2015; Focus Theme: Early Graft Failure, 10.1016/j.healun.2015.08.014
  4. Keogh Anne, Calcineurin inhibitors in heart transplantation, 10.1016/j.healun.2004.03.008
  5. Zuckermann Andreas Oliver, Aliabadi Arezu Z., Calcineurin-inhibitor minimization protocols in heart transplantation, 10.1111/j.1432-2277.2008.00771.x
  6. Mehra M. R., Contemporary Concepts in Prevention and Treatment of Cardiac Allograft Vasculopathy, 10.1111/j.1600-6143.2006.01314.x
  7. Halloran Philip F., Immunosuppressive Drugs for Kidney Transplantation, 10.1056/nejmra033540
  8. Schuurman H.-J, Pally C, Weckbecker G, Schuler W, Bruns C, SDZ RAD inhibits cold ischemia-induced vascular remodeling, 10.1016/s0041-1345(98)01885-5
  9. Viganò Mario, Tuzcu Murat, Benza Raymond, Boissonnat Pascale, Haverich Axel, Hill James, Laufer Guenther, Love Robert, Parameshwar Jayan, Pulpón Luis Alonso, Renlund Dale, Abeywickrama Kamal, Cretin Nathalie, Starling Randall C., Eisen Howard J., Prevention of Acute Rejection and Allograft Vasculopathy by Everolimus in Cardiac Transplants Recipients: A 24-Month Analysis, 10.1016/j.healun.2007.03.005
  10. Kobashigawa Jon A., Pauly Daniel F., Starling Randall C., Eisen Howard, Ross Heather, Wang Shoei-Shen, Cantin Bernard, Hill James A., Lopez Patricia, Dong Gaohong, Nicholls Stephen J., Cardiac Allograft Vasculopathy by Intravascular Ultrasound in Heart Transplant Patients, 10.1016/j.jchf.2013.07.002
  11. Arora S., Andreassen A. K., Andersson B., Gustafsson F., Eiskjaer H., Bøtker H. E., Rådegran G., Gude E., Ioanes D., Solbu D., Sigurdardottir V., Dellgren G., Erikstad I., Solberg O. G., Ueland T., Aukrust P., Gullestad L., , The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy inDe NovoRecipients: One-Year Results of a Scandinavian Randomized Trial : Everolimus and Cardiac Allograft Vasculopathy, 10.1111/ajt.13214
  12. Avery Robin K., Cardiac-Allograft Vasculopathy, 10.1056/nejmp038124
  13. Viganò M., Dengler T., Mattei M.F., Poncelet A., Vanhaecke J., Vermes E., Kleinloog R., Li Y., Gezahegen Y., Delgado J.F., , Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil inde novocardiac transplant recipients: a randomized, multicenter study, 10.1111/j.1399-3062.2009.00448.x
  14. Hill James A., Hummel Manfred, Starling Randall C., Kobashigawa Jon A., Perrone Sergio V., Arizón Josè M., Simonsen Svein, Abeywickrama Kamal H., Bara Christoph, A Lower Incidence of Cytomegalovirus Infection in De Novo Heart Transplant Recipients Randomized to Everolimus : , 10.1097/01.tp.0000290686.68910.bd
  15. Kobashigawa J., Ross H., Bara C., Delgado J.F., Dengler T., Lehmkuhl H.B., Wang S.-S., Dong G., Witte S., Junge G., Potena L., Everolimus is associated with a reduced incidence of cytomegalovirus infection followingde novocardiac transplantation, 10.1111/tid.12007
  16. Motzer Robert J, Escudier Bernard, Oudard Stéphane, Hutson Thomas E, Porta Camillo, Bracarda Sergio, Grünwald Viktor, Thompson John A, Figlin Robert A, Hollaender Norbert, Urbanowitz Gladys, Berg William J, Kay Andrea, Lebwohl David, Ravaud Alain, Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial, 10.1016/s0140-6736(08)61039-9
  17. Euvrard Sylvie, Boissonnat Pascale, Roussoulières Ana, Kanitakis Jean, Decullier Evelyne, Claudy Alain, Sebbag Laurent, Effect of everolimus on skin cancers in calcineurin inhihitor-treated heart transplant recipients : Letter to the editor, 10.1111/j.1432-2277.2009.01010.x
  18. Doesch Andreas, Rivinius Rasmus, Helmschrott Matthias, Ruhparwar Arjang, Schmack Bastian, Klein Berthold, Erbel Christian, Gleissner Christian A, Akhavanpoor Mohammadreza, Frankenstein Lutz, Darche Fabrice F, Thomas Dierk, Ehlermann Philipp, Bruckner Tom, Katus Hugo A, Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy, 10.2147/dddt.s75464
  19. Eisen Howard J., Tuzcu E. Murat, Dorent Richard, Kobashigawa Jon, Mancini Donna, Valantine-von Kaeppler Hannah A., Starling Randall C., Sørensen Keld, Hummel Manfred, Lind Joan M., Abeywickrama Kamal H., Bernhardt Peter, Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients, 10.1056/nejmoa022171
  20. Eisen H. J., Kobashigawa J., Starling R. C., Pauly D. F., Kfoury A., Ross H., Wang S.-S., Cantin B., Van Bakel A., Ewald G., Hirt S., Lehmkuhl H., Keogh A., Rinaldi M., Potena L., Zuckermann A., Dong G., Cornu-Artis C., Lopez P., Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial : Everolimus Versus MMF in Heart Transplantation, 10.1111/ajt.12181
  21. Andreassen A. K., Andersson B., Gustafsson F., Eiskjaer H., Rådegran G., Gude E., Jansson K., Solbu D., Sigurdardottir V., Arora S., Dellgren G., Gullestad L., , Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial : Early Switch to Everolimus Posttransplant, 10.1111/ajt.12809
  22. González-Vílchez Francisco, Vázquez de Prada José Antonio, Exṕosito Víctor, García-Camarero Tamara, Fernández-Friera Leticia, Llano Miguel, Ruano Javier, Martín-Durán Rafael, Avoidance of Calcineurin Inhibitors With Use of Proliferation Signal Inhibitors in De Novo Heart Transplantation With Renal Failure, 10.1016/j.healun.2008.07.020
  23. Gonzalez-Vilchez Francisco, Vazquez de Prada José Antonio, Almenar Luis, Arizon del Prado José María, Mirabet Sonia, Diaz-Molina Beatriz, Delgado Juan Francisco, Gomez-Bueno Manuel, Paniagua María Jesús, Perez-Villa Félix, Roig Eulalia, Martínez-Dolz Luis, Brossa Vicens, Lambert José Luis, Segovia Javier, Crespo-Leiro María Generosa, Ruiz-Cano María Jesús, Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation, 10.1016/j.healun.2011.10.011
  24. Stewart Susan, Winters Gayle L., Fishbein Michael C., Tazelaar Henry D., Kobashigawa Jon, Abrams Jacki, Andersen Claus B., Angelini Annalisa, Berry Gerald J., Burke Margaret M., Demetris Anthony J., Hammond Elizabeth, Itescu Silviu, Marboe Charles C., McManus Bruce, Reed Elaine F., Reinsmoen Nancy L., Rodriguez E. Rene, Rose Alan G., Rose Marlene, Suciu-Focia Nicole, Zeevi Adriana, Billingham Margaret E., Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection, 10.1016/j.healun.2005.03.019
  25. Lehmkuhl Hans B., Arizon José, Viganò Mario, Almenar Luis, Gerosa Gino, Maccherini Massimo, Varnous Shaida, Musumeci Francesco, Hexham J Mark, Mange Kevin C., Livi Ugolino, Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients : , 10.1097/tp.0b013e3181aacd22
  26. Zuckermann Andreas, Wang Shoei-Shen, Ross Heather, Frigerio Maria, Eisen Howard J., Bara Christoph, Hoefer Daniel, Cotrufo Maurizio, Dong Gaohong, Junge Guido, Keogh Anne M., Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids inde novoHeart Transplant Patients: A Multicentre, Randomized Trial, 10.1155/2011/535983
  27. Wang S.-S., Chou N.-K., Chi N.-H., Huang S.-C., Wu I.-H., Wang C.-H., Yu H.-Y., Chen Y.-S., Tsao C.-I., Ko W.-J., Shun C.-T., Can Cyclosporine Blood Level Be Reduced to Half After Heart Transplantation?, 10.1016/j.transproceed.2010.03.014
  28. Potena Luciano, Prestinenzi Paola, Bianchi Isidoro G., Masetti Marco, Romani Paolo, Magnani Gaia, Fallani Francesco, Coccolo Fabio, Russo Antonio, Ponticelli Claudio, Rapezzi Claudio, Grigioni Francesco, Branzi Angelo, Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study, 10.1016/j.healun.2012.01.002
  29. Bara C., Dengler T., Hack M.A., Ladenburger S., Lehmkuhl H.B., A 1-Year Randomized Controlled Study of Everolimus Versus Mycophenolate Mofetil With Reduced-Dose Cyclosporine in Maintenance Heart Transplant Recipients, 10.1016/j.transproceed.2013.03.032
  30. Gullestad Lars, Iversen Martin, Mortensen Svend-Aage, Eiskjær Hans, Riise Gerdt C., Mared Lena, Bjørtuft Øystein, Ekmehag Björn, Jansson Kjell, Simonsen Svein, Gude Einar, Rundqvist Bengt, Fagertun Hans E., Solbu Dag, Bergh Claes-Håkan, Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial : , 10.1097/tp.0b013e3181cbac2d
  31. Gude Einar, Gullestad Lars, Arora Satish, Simonsen Svein, Hoel Ina, Hartmann Anders, Holdaas Hallvard, Fiane Arnt E., Geiran Odd R., Andreassen Arne K., Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation, 10.1016/j.healun.2010.01.005
  32. Lehmkuhl Hans B., Mai Daniel, Dandel Michael, Knosalla Christoph, Hiemann Nicola E., Grauhan Onnen, Huebler Michael, Pasic Miralem, Weng Yuguo, Meyer Rudolph, Rothenburger Markus, Hummel Manfred, Hetzer Roland, Observational Study With Everolimus (Certican) in Combination With Low-dose Cyclosporine in De Novo Heart Transplant Recipients, 10.1016/j.healun.2007.02.008
  33. Arora Satish, Gude Einar, Sigurdardottir Vilborg, Mortensen Svend Aage, Eiskjær Hans, Riise Gerdt, Mared Lena, Bjørtuft Øystein, Ekmehag Bjørn, Jansson Kjell, Simonsen Svein, Aukrust Pål, Solbu Dag, Iversen Martin, Gullestad Lars, Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: The significance of baseline glomerular filtration rate, 10.1016/j.healun.2011.12.010
  34. Andreassen A. K., Andersson B., Gustafsson F., Eiskjaer H., Rådegran G., Gude E., Jansson K., Solbu D., Karason K., Arora S., Dellgren G., Gullestad L., , Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal inDe NovoHeart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study : Early Switch to Everolimus After Transplant, 10.1111/ajt.13588
  35. Deuse Tobias, Bara Christoph, Barten Markus J., Hirt Stephan W., Doesch Andreas O., Knosalla Christoph, Grinninger Carola, Stypmann Jörg, Garbade Jens, Wimmer Peter, May Christoph, Porstner Martina, Schulz Uwe, The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation, 10.1016/j.cct.2015.09.009
  36. Gullestad Lars, Eiskjaer Hans, Gustafsson Finn, Riise Gerdt C., Karason Kristjan, Dellgren Göran, Rådegran Göran, Hansson Lennart, Gude Einar, Bjørtuft Øystein, Jansson Kjell, Schultz Hans Henrik, Solbu Dag, Iversen Martin, Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial, 10.1111/tri.12783
  37. Zuckermann A., Keogh Anne, Crespo-Leiro M. G., Mancini D., Vilchez F. González, Almenar L., Brozena S., Eisen H., Tai S. See, Kushwaha S., Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency : Sirolimus in Cardiac Transplant Recipients, 10.1111/j.1600-6143.2012.04131.x
Bibliographic reference Van Keer, Jan ; Derthoo, David ; Van Caenegem, Olivier ; De Pauw, Michel ; Nellessen, Eric ; et. al. The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial. In: Journal of Transplantation, Vol. 2017, no.2017, p. 1-8 (2017)
Permanent URL http://hdl.handle.net/2078.1/183905